WO2019128081A1 - 一种检测和分析dna的方法 - Google Patents
一种检测和分析dna的方法 Download PDFInfo
- Publication number
- WO2019128081A1 WO2019128081A1 PCT/CN2018/088762 CN2018088762W WO2019128081A1 WO 2019128081 A1 WO2019128081 A1 WO 2019128081A1 CN 2018088762 W CN2018088762 W CN 2018088762W WO 2019128081 A1 WO2019128081 A1 WO 2019128081A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- dna
- sample
- curve
- melting time
- fluorescence brightness
- Prior art date
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
Definitions
- the invention relates to the field of biotechnology, and in particular to a method for detecting and analyzing DNA.
- PCR polymerase chain reaction
- the PCR product can be further detected by probe, DNA sequencing, capillary electrophoresis or DNA melting curve analysis (MCA), and then further genetic information can be further explored.
- MCA DNA melting curve analysis
- the simplicity and specificity of MCA make it the most promising analysis method for rapid detection of epigenetic differences, point mutations and single nucleotide polymorphism (SNP) detection in single reaction tubes.
- SNP single nucleotide polymorphism
- MCA typically requires raising the temperature from 30 ° C to 90 ° C.
- the Dodge team analyzed the melting process of the immobilized oligonucleotide (34-bp) from the molecular beacon probe and found that it took 5 seconds for each temperature gradient to stabilize the temperature.
- the Piunno team also performed a melting analysis of the immobilized fluorescently labeled oligonucleotide duplex (20-bp); during the course of the experiment, the tester also measured the fluorescence while also measuring it at about 0.005 ° C / The rate of s is heated.
- the sample temperature is stable and the DNA probe is homogeneously reacted by inserting the necessary temperature stabilization step or maintaining a slow heating rate during the thermal scanning distribution.
- the sample heating rate can be as high as 175 ° C / s, these steps will slow down the entire melting process.
- the current method for expressing the DNA dissolution curve is the curve of the heating temperature and the fluorescence intensity of the DNA. Using this method requires monitoring and calibrating the heating temperature in real time during the observation process, which slows down the DNA melting process and analyzes The process is also cumbersome.
- a method of detecting DNA comprising the steps of:
- the melting time-fluorescence brightness curve of the control DNA was compared with the melting time-fluorescence brightness curve of the test sample DNA to obtain the detection result.
- control group was a blank control group.
- control group is standard DNA.
- control group is DNA of a known mutation type.
- a molecular beacon probe and a DNA target are placed in the reaction solution, and the reaction solution is heated, and at the same time, the fluorescence signal is recorded to obtain a melting time-fluorescence luminance curve of the DNA.
- the heating curves of the heating process are consistent.
- its fluorescent signal is recorded in real time.
- the method is used for DNA mutation detection or DNA homology detection or detection of target DNA.
- a method for detecting DNA which is characterized in that the detection result of the target DNA is obtained by obtaining a melting time-fluorescence luminance curve of the test sample DNA.
- Another object of the present invention is to provide a method of analyzing DNA which does not require observation of the heating temperature.
- a method of analyzing DNA by obtaining a melting time-fluorescence brightness curve of DNA.
- a molecular beacon probe and a DNA target are placed in the reaction solution, and the reaction solution is heated, and at the same time, the fluorescence signal is recorded to obtain a melting time-fluorescence luminance curve of the DNA.
- the invention detects and analyzes DNA by obtaining the melting time-fluorescence brightness curve of DNA. Compared with the temperature-fluorescence brightness curve currently used for detecting and analyzing DNA, it is not necessary to accurately monitor and calibrate the heating temperature in real time, which speeds up its acceleration.
- the analysis process makes the DNA detection and analysis process simple and fast.
- Figure 2 is a flow chart showing the implementation of DNA detection and analysis in the first embodiment.
- 3 is a time-fluorescence brightness curve of the blank sample and the test sample corresponding to the first embodiment
- FIG. 5 is a time-fluorescence brightness curve of the test sample corresponding to the second embodiment
- Figure 6 is a flow chart showing the third embodiment of DNA detection and analysis.
- Figure 7 is a time-fluorescence brightness curve of the standard DNA and the test sample corresponding to Example 3.
- Figure 8 is a flow chart showing the fourth embodiment of DNA detection and analysis.
- Figure 10 is a flow chart showing the fifth embodiment of DNA detection and analysis.
- Figure 11 is a time-fluorescence brightness curve of the test sample (different type of variant site) corresponding to the fifth embodiment
- Figure 12 is a heating curve of the heating process corresponding to the first, second, third, fourth and fifth embodiments.
- the left side frame 110 shown in FIG. 1 is that the sample to be tested 111 (the sample corresponding to the paired molecular beacon probe) is heated according to the set temperature heating curve 112 (which may be a heating curve as shown in FIG. 12). . During the heating process, the fluorescence brightness of the sample is recorded in real time to obtain a time-fluorescence brightness curve 113.
- the test sample contains the target gene sequence 116.
- the right side frame 120 shown in Fig. 1 is based on DNA detection and continues to analyze the sample to be tested having the target gene sequence 116.
- the standard sample [0] 121 is a sample containing the target DNA without any variation and the corresponding paired molecular beacon probe.
- the heating curve 122 used for heating the standard sample [0] 121 coincides with the temperature heating curve 112 during the heating of the sample to be tested.
- the fluorescence brightness of the sample is recorded in real time to obtain a time-fluorescence brightness curve 123.
- the time-fluorescence brightness curve 123 of the standard sample [0] 121 and the time-fluorescence brightness curve 113 of the sample 111 to be tested containing the target gene sequence 116 were compared.
- the gene sequence contained in the sample 111 to be tested is identical to the gene sequence contained in the standard sample [0] 121, and also indicates that there is no genetic variation in the gene sequence contained in the sample 111 to be tested. Wild Type 124. If the two sets of curves do not overlap, it means that the gene sequence contained in the sample 111 to be tested has a genetic variation, which is Mutant Type 125.
- the standard sample [0]121 is replaced with a blank control sample, it can be used to determine the target gene sequence in the sample to be tested, or the target gene sequence is too small, or the target gene sequence gene mutation site More, if the change is obvious, it means that the test sample contains the target gene sequence.
- the standard sample [N] 126 is a sample set containing a target DNA of a specific mutation and a corresponding paired molecular beacon probe.
- the sample in the standard sample [N] 126 is heated separately, and the heating curve 127 used for heating is identical to the temperature heating curve 112 during the heating process of the sample to be tested.
- the fluorescence brightness of the sample is recorded in real time to obtain a time-fluorescence brightness curve set 128.
- the acquired time-fluorescence brightness curve group 128 extracts a time-fluorescence brightness curve 113 corresponding to the sample 111 to be tested containing the gene variation 125.
- the alignment result matching can confirm the number of mutation sites of the target gene in the sample 111 to be tested, or the base type 128 of the mutation site.
- FIG. 2 A method for detecting and analyzing the presence or absence of target DNA, the principle of the experimental method is shown in Fig. 2, that is, the sample to be tested and the blank sample are separately heated.
- a blank sample 200 is taken and a sufficient number of designed molecular beacon probes 5'-CY3-TCTACGCCACCAGCTCA-BHQ2-3' are added to the blank sample.
- the above samples 210 and 200 are respectively heated, and the heating method adopts the heating curve 1200 described in FIG. 12 (other heating curves may be used as long as the sample to be tested and the blank sample maintain the heating curve in the comparison test)
- the fluorescence brightness corresponding to the samples 210 and 200 is recorded in real time using a fluorescent brightness detecting device.
- a time-fluorescence brightness curve as shown in FIG. 3 is obtained, wherein the sample-to-test sample 210 corresponds to a melting time-fluorescence brightness curve of 310, and the blank sample 200 corresponds to a melting time-fluorescence brightness curve of 300.
- the melting time-fluorescence brightness curve 300 of the blank sample is compared to the melting time-fluorescence brightness curve 310 of the sample DNA to be detected.
- the melting time-fluorescence brightness curve 310 can be obtained corresponding to the detection sample 210 which does not contain the target DNA or contains too little target DNA or contains too many target DNA variation sites.
- a method for detecting and analyzing the presence or absence of a target DNA, and the principle of the experimental method is as shown in FIG. 4, that is, the sample to be tested is heated.
- the sample 400 to be tested is separately heated, and the heating method adopts the heating curve 1200 shown in FIG. 12 (other heating curves can of course be used), and the fluorescence brightness corresponding to the sample 400 to be tested is recorded in real time using a fluorescence microscope.
- a time-fluorescence brightness curve as shown in FIG. 5 is obtained, and the melting time-fluorescence brightness curve corresponding to the sample 400 to be tested is 500.
- melting time-fluorescence brightness curve 500 Observing the melting time-fluorescence brightness curve 500 can be obtained, and the melting time-fluorescence brightness curve 500 corresponds to the detection sample 400 containing the target DNA.
- Fig. 6 A method for detecting and analyzing the homology of DNA.
- the principle of the experimental method is shown in Fig. 6, that is, the samples to be tested and the standard DNA (without any mutation) are separately heated.
- the above samples 610, 620, and 600 are respectively heated, and the heating method adopts the heating curve 1200 described in FIG. 12 (other heating curves may be used as long as the sample to be tested and the standard DNA sample are kept in the comparison test)
- the temperature curve is uniform, and the fluorescence brightness corresponding to the samples 610, 620, and 600 is recorded in real time using the fluorescent brightness detecting device.
- a time-fluorescence brightness curve as shown in FIG. 7 is obtained, wherein the melting time-fluorescence brightness curve corresponding to sample 610 is 710, and the melting time-fluorescence brightness curve corresponding to sample 620 is 720, and the melting time corresponding to sample 600 is -
- the fluorescence brightness curve is 700.
- the melting time-fluorescence brightness curve 700 of the standard DNA sample is compared to the melting time-fluorescence brightness curves 710, 720 of the sample DNA to be detected. It can be obtained that the melting time-fluorescence brightness curve 710 corresponds to the detection sample 610 containing the target DNA, and the melting time-fluorescence brightness curve 720 corresponds to the detection sample 620 does not contain the target DNA or the amount of target DNA contained is too small or contains the target DNA variation position. Too many points.
- a method for detecting and analyzing the number of sites in which a DNA gene is mutated, and the principle of the experimental method is as shown in Fig. 8, that is, heating the sample to be tested (determining that a gene mutation has occurred).
- the above samples 810A, 810B, 820A, 820B, 830A, 830B, 840 are respectively heated, and the heating method adopts the heating curve 1200 described in FIG. 12 (other heating curves can be used as long as they are in the comparison test).
- the sample is consistent with the DNA sample of the gene mutation type to maintain the heating curve, and the fluorescence brightness corresponding to the samples 810A, 810B, 820A, 820B, 830A, 830B, 840 is recorded in real time using the fluorescence brightness detecting device.
- the melting time-fluorescence brightness curve corresponding to sample 810A is 910A
- the melting time-fluorescence brightness curve corresponding to sample 810B is 910B
- the melting time corresponding to sample 820A is 920A
- the melting time-fluorescence brightness curve corresponding to sample 820B is 920B
- the melting time-fluorescence brightness curve corresponding to sample 830A is 930A
- the melting time-fluorescence brightness curve corresponding to sample 830B is 930B.
- the melting time-fluorescence brightness curves 910A, 920A, 920A of the DNA samples of known gene mutation types are compared with the melting time-fluorescence brightness curves 910B, 920B, 930B of the sample DNA to be detected, and the corresponding curves are highly coincident and simultaneously The value of the corresponding curve is put into the Pearson correlation coefficient formula to obtain the correlation curve corresponding to 0.999. Can get:
- the melting time-fluorescence brightness curve 910B corresponds to 5 gene mutation sites in the target DNA in the detection sample (No. 810B);
- the melting time-fluorescence brightness curve 920B corresponds to 6 gene mutation sites in the target DNA in the detection sample (No. 820B);
- the melting time-fluorescence brightness curve 930B corresponds to 7 gene mutation sites in the target DNA in the detection sample (No. 830B).
- a method for detecting and analyzing the number of sites in which a DNA gene is mutated and the base type of a mutated base site, and the principle of the experimental method is as shown in FIG. 10, that is, a sample to be tested (determination of a gene mutation has occurred), a known gene A mutant type of DNA sample is warmed.
- the above samples 1010A, 1010B, 1020A, 1020B, 1030A, 1030B are respectively heated, and the heating method adopts the heating curve 1200 described in FIG. 12 (other heating curves can be used as long as the sample to be tested in the comparison test) It is sufficient to maintain the heating curve with the DNA sample of the genetic mutation type, and the fluorescence brightness corresponding to the samples 1010A, 1010B, 1020A, 1020B, 1030A, and 1030B is recorded in real time using the fluorescence brightness detecting device.
- the melting time-fluorescence brightness curve corresponding to sample 1010A is 1110 A
- the melting time-fluorescence brightness curve corresponding to sample 1010B is 1110 B
- the melting time corresponding to sample 1020A is obtained.
- the fluorescence brightness curve is 1120A
- the melting time curve of the sample 1020B is 1120B
- the melting time curve of the sample 1030A is 1130A
- the melting time of the sample 1030B is 1130B.
- the melting time-fluorescence brightness curve corresponding to 1040 is 1140.
- the melting time-fluorescence brightness curves 1110A, 1120A, 1120A of the DNA samples of the known gene mutation type are compared with the melting time-fluorescence brightness curves 1110B, 1120B, 1130B of the DNA of the sample to be detected, and the corresponding curves are highly coincident and simultaneously The value of the corresponding curve is put into the Pearson correlation coefficient formula to obtain the correlation curve corresponding to 0.999. Can get:
- the melting time-fluorescence brightness curve 1110B corresponds to one target gene mutation site in the target DNA in the detection sample 1010B, and the variant base is changed from the original G to A;
- the melting time-fluorescence brightness curve 1120B corresponds to one target gene mutation site in the target DNA in the detection sample 1020B, and the variant base is changed from the original G to T;
- the melting time-fluorescence luminance curve 1130B corresponds to one gene mutation site in the target DNA in the detection sample 1030B, and the variant base is changed from the original G to C.
- the method can be used to detect DNA mutations and their numbers, base types of mutated base sites or single nucleotide polymorphism genotyping (SNP).
- SNP single nucleotide polymorphism genotyping
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
Abstract
一种检测DNA的方法,其包括如下步骤:获取对照组DNA的解链时间-荧光亮度曲线;获取检测样品DNA的解链时间-荧光亮度曲线;将对照组DNA的解链时间-荧光亮度曲线与检测样品DNA的解链时间-荧光亮度曲线进行比较,获得检测结果。所述对照组为空白对照组或为标准DNA或为已知突变类型的DNA。
Description
本发明涉及生物技术领域,具体涉及一种检测和分析DNA的方法。
面对快速传播的传染性疾病,迅速而准确的诊断关乎病人的生死,也与病人身边的亲属、朋友有着莫大的关系。为了降低将样品运输到专门实验室以寻找病原体或潜在突变DNA所花的时间和资金成本,研究人员致力于寻找更快速准确的工具以满足这些诊断需求。以聚合酶链反应(PCR)为基础的分子诊断方法是接受最为广泛的诊断方法之一,该方法可以以相对便宜的价格获取准确、全面的诊断信息。
在试验中,可以通过探针、DNA测序、毛细管电泳或DNA解链曲线分析(MCA)来进一步检测PCR的产物,继而进一步发掘更多的遗传信息。其中,MCA的简单性和特异性使其成为了对单反应管快速检测表观遗传差异,点突变和单核苷酸多态性(SNP)检测方面最有前景的分析方式。为使DNA熔解,MCA通常需要把温度从30℃升至90℃。Dodge团队分析了来自分子信标探针的固定寡核苷酸(34-bp)的熔化过程,发现在每个温度梯度下都需要有5秒时间来使温度稳定。就同一个问题,Piunno团队也对固定荧光标记的寡核苷酸双链体(20-bp)进行了熔解分析;在实验过程,试验人员在连续测量荧光的同时也对其以约0.005℃/s的速率进行加热。对于鉴别敏感的DNA来说,研究人员有必要在热扫描分布过程中通过插入必要的温度稳定步骤或保持缓慢的加热速率来确保样品温度稳定和DNA探针的均匀反应。尽管样品加热速率可高达175℃/s,但是这些步骤仍会减缓整个熔化过程。从上可以看出,目前用于表达DNA溶解曲线的方式为加热温度与DNA荧光亮度的曲线,使用该方法需要在观测过程中实时对加热温度进行监 控和校准,会减缓DNA解链过程,分析过程也比较繁琐。
发明内容
本发明的目的在于提供一种不需要观测加热温度的检测DNA的方法。
本发明的目的是通过如下技术方案实现的:
一种检测DNA的方法,其包括如下步骤:
获取对照组DNA的解链时间-荧光亮度曲线;
获取检测样品DNA的解链时间-荧光亮度曲线;
将对照组DNA的解链时间-荧光亮度曲线与检测样品DNA的解链时间-荧光亮度曲线进行比较,获得检测结果。
特别地,所述对照组为空白对照组。
特别地,所述对照组为标准DNA。
特别地,所述对照组为已知突变类型的DNA。
特别地,在反应溶液中放入分子信标探针和DNA靶,对反应溶液进行加温,同时,对其荧光信号进行记录,获取DNA的解链时间-荧光亮度曲线。
特别地,在获取对照组DNA和获取检测样品DNA的解链时间-荧光亮度曲线过程中,两者加温过程的加温曲线保持一致。
特别地,对其荧光信号进行实时记录。
特别地,该方法用于DNA突变检测或DNA同源检测或目标DNA有无检测。
一种检测DNA的方法,其特征在于,通过获取检测样品DNA的解链时间-荧光亮度曲线获得有或无目标DNA的检测结果。
本发明的另一个目的在于提供一种不需要观测加热温度的分析DNA的方法。
本发明的另一个目的是通过如下技术方案实现的:
一种通过获取DNA的解链时间-荧光亮度曲线分析DNA的方法。
特别地,在反应溶液中放入分子信标探针和DNA靶,对反应溶液进行加温,同时,对其荧光信号进行记录,获取DNA的解链时间-荧光亮度曲线。
本发明通过获取DNA的解链时间-荧光亮度曲线来检测和分析DNA,相比目前用于检测和分析DNA的温度-荧光亮度曲线,不需要实时对加热温度进行精确监控和校准,加快了其分析过程,使得DNA检测和分析过程变得简便和快捷。
图1为根据本发明实施DNA检测分析的原理流程图;
图2为实施例一实施DNA检测和分析的流程图。
图3为实施例一所对应的空白样品和检测样品的时间-荧光亮度曲线;
图4为实施例二实施DNA检测和分析的流程图。
图5为实施例二所对应的检测样品的时间-荧光亮度曲线;
图6为实施例三实施DNA检测和分析的流程图。
图7为实施例三所对应的标准DNA和检测样品的时间-荧光亮度曲线;
图8为实施例四实施DNA检测和分析的流程图。
图9为实施例四所对应的检测样品(不同变异位点数量)的时间-荧光亮度曲线;
图10为实施例五实施DNA检测和分析的流程图。
图11为实施例五所对应的检测样品(变异位点不同类型)的时间-荧光亮度曲线;
图12为实施例一、二、三、四、五所对应的加热过程的加温曲线。
下面,将参照附图详细地描述本发明的具体实现原理。
如图1所示,为本发明实施检测和分析DNA方法的原理。图1所示的左侧框110,是先对待测样品111(对应配对的分子信标探针的样品)按照设定的温度加热曲线112(可以是如图12所示的加热曲线)进行加热。在加热的过程中,对样品的荧光亮度被实时记录,以获取时间-荧光亮度曲线 113。
观察获得的时间-荧光亮度曲线113中荧光亮度随时间的变化程度,若变化不明显则表示,待测样品中无目标基因序列,或目标基因序列数量过少,或目标基因序列基因变异位点过多115,若变化明显则表示测试样品中含有目标基因序列116。
如图1所示的右侧框120是在DNA检测的基础上,继续对有目标基因序列116的待测样品进行分析。
标准样品【0】121是含有无任何变异的目标DNA和对应配对的分子信标探针的样品。对标准样品【0】121加热使用的加热曲线122与对待检测样品的加温过程中温度加热曲线112一致。在加热的过程中,对样品的荧光亮度被实时记录,以获取时间-荧光亮度曲线123。对比标准样品【0】121的时间-荧光亮度曲线123和含有目标基因序列116的待测样品111的时间-荧光亮度曲线113。若两组曲线重叠,则表示待测样品111中所含有的基因序列与标准样品【0】121中含有的基因序列一致,同样表明待测样品111中所含有的基因序列中没有基因变异,为Wild Type 124。若两组曲线不重叠,则表示待测样品111中含有的基因序列有基因变异,为Mutant Type 125。
在此过程中,如果将标准样品【0】121换成空白对照样品,就可以用来确定待测样品中无目标基因序列,或目标基因序列数量过少,或目标基因序列基因变异位点过多,若变化明显则表示测试样品中含有目标基因序列。
标准样品【N】126是含有特定变异的目标DNA和对应配对的分子信标探针的样品组。分别对标准样品【N】126中的样品加热,加热使用的加热曲线127与对待检测样品的加温过程中温度加热曲线112一致。在加热的过程中,对样品的荧光亮度被实时记录,以获取时间-荧光亮度曲线组128。获取的时间-荧光亮度曲线组128中抽取比对含有基因变异125的待测样品111对应的时间-荧光亮度曲线113。比对结果匹配可确认待测样品111中的目标基因的变异位点数量,或变异位点的碱基类型128。
实施例一
一种检测和分析是否存在目标DNA的方法,实验方法原理如图2所示,即分别对待测样品、空白样品进行加温。
实验准备:
1、取待测样品210,并在待测样品中只加入了足够数量的设计的分子信标探针5’-CY3-TCTACGCCACCAGCTCA-BHQ2-3’。
2、取空白样品200,并在空白样品中加入了足够数量的设计的分子信标探针5’-CY3-TCTACGCCACCAGCTCA-BHQ2-3’。
3、准备可对加热温度曲线进行控制的加温设备。
4、准备荧光亮度检测设备。
实验并记录:
分别对上述样品210、200进行加温,加温方式均采用图12所述的加温曲线1200(当然可以采用其他加温曲线,只要在对比测试中待测样品与空白样品保持加温曲线一致即可),并使用荧光亮度检测设备分别对样品210、200对应的荧光亮度实时记录。得到如图3所示的时间-荧光亮度曲线,其中,待测样品210对应的解链时间-荧光亮度曲线为310,空白样品200对应的解链时间-荧光亮度曲线为300。
结论
将空白样品的解链时间-荧光亮度曲线300与待检测样品DNA的解链时间-荧光亮度曲线310进行比较。可以得到解链时间-荧光亮度曲线310对应检测样品210不含有目标DNA或所含目标DNA数量太少或所含目标DNA变异位点过多。
实施例二
一种检测和分析是否存在目标DNA的方法,实验方法原理如图4所示,即对待测样品进行加温。
实验准备:
1、取待测样品400,并在待测样品中只加入了足够数量的设计的分子 信标探针5’-CY3-TCTACGCCACCAGCTCA-BHQ2-3’。
2、准备可对加热温度曲线进行控制的加温设备。
3、准备荧光亮度检测设备。
实验并记录:
分别对上述待测样品400进行加温,加温方式均采用图12所述的加温曲线1200(当然可以采用其他加温曲线),并使用荧光显微镜对待测样品400对应的荧光亮度实时记录。得到如图5所示的时间-荧光亮度曲线,待测样品400对应的解链时间-荧光亮度曲线为500。
结论
观察解链时间-荧光亮度曲线500可以得到,解链时间-荧光亮度曲线500对应检测样品400含有目标DNA。
实施例三
一种检测和分析DNA是否同源的方法,实验方法原理如图6所示,即分别对待测样品、标准DNA(未发生任何突变)样品进行加温。
实验准备:
1、取标准DNA样品600,并在标准DNA样品中加入了人类KRAS基因片段单链DNA 5’-GTAGTTGGAGCTGGTGGCGTAGGCAAGAGT-3’及足够数量的设计的分子信标探针5’-CY3-TCTACGCCACCAGCTCA-BHQ2-3’;
2、取待测样品610,并在待测样品中加入了人类KRAS基因片段单链DNA5’-GTAGTTGGAGCTGGTGGCGTAGGCAAGAGT-3’及足够数量的设计的分子信标探针5’-CY3-TCTACGCCACCAGCTCA-BHQ2-3’;
3、取待测样品620,并在待测样品中只加入了足够数量的设计的分子信标探针5’-CY3-TCTACGCCACCAGCTCA-BHQ2-3’。
4、准备可对加热温度曲线进行控制的加温设备。
5、准备荧光亮度检测设备。
实验并记录:
分别对上述样品610、620、600进行加温,加温方式均采用图12所述 的加温曲线1200(当然可以采用其他加温曲线,只要在对比测试中待测样品与标准DNA样品保持加温曲线一致即可),并使用荧光亮度检测设备分别对样品610、620、600对应的荧光亮度实时记录。得到如图7所示的时间-荧光亮度曲线,其中,样品610对应的解链时间-荧光亮度曲线为710,样品620对应的解链时间-荧光亮度曲线为720,样品600对应的解链时间-荧光亮度曲线为700。
结论
将标准DNA样品的解链时间-荧光亮度曲线700与待检测样品DNA的解链时间-荧光亮度曲线710、720进行比较。可以得到,解链时间-荧光亮度曲线710对应检测样品610含有目标DNA,解链时间-荧光亮度曲线720对应检测样品620不含有目标DNA或所含目标DNA数量太少或所含目标DNA变异位点过多。
实施例四
一种检测和分析DNA基因突变的位点数量的方法,实验方法原理如图8所示,即分别对待测样品(确定已发生基因突变)进行加温。
实验准备:
1、取已知基因突变类型的DNA样品810A,并在已知基因突变类型的DNA样品810A中加入了设计的单链DNA5′-ATCGATTAGGGTGTCCAGCGCGAGCGGTGGGCTAGCTCAT-3′及足够数量的设计的分子信标探针5′-CY5-TAGCCCTCCGCTCCCGCAGGCCACGCTA-BHQ2-3′;所述设计的单链DNA 5′-ATCGATTAGGGTGTCCAGCGCGAGCGGTGGGCTAGCTCAT-3′与计的分子信标探针5’-CY5-TAGCCCTCCGCTCCCGCAGGCCACGCTA-BHQ2-3′之间有5个基因突变位点。
2、取待测样品810B,并在待测样品810B中加入了设计的单链DNA5′-ATCGATTAGGGTGTCCAGCGCGAGCGGTGGGCTAGCTCAT-3′及足够数量的设计的分子信标探针5′-CY5-TAGCCCTCCGCTCCCGCAGGCCACGCTA-BHQ2-3′;
3、取已知基因突变类型的DNA样品820A,并在已知基因突变类型的DNA样 品820A中加入了设计的单链DNA5′-ATCGATTAGGGTGTCCAGCGCGCGCGGTGGGCTAGCTCAT-3′及足够数量的设计的分子信标探针5′-CY5-TAGCCCTCCGCTCCCGCAGGCCACGCTA-BHQ2-3′;所述设计的单链DNA 5′-ATCGATTAGGGTGTCCAGCGCGCGCGGTGGGCTAGCTCAT-3′与计的分子信标探针5’-CY5-TAGCCCTCCGCTCCCGCAGGCCACGCTA-BHQ2-3′之间有6个基因突变位点。
4、取待测样品820B,并在待测样品820B中加入了设计的单链DNA5′-ATCGATTAGGGTGTCCAGCGCGCGCGGTGGGCTAGCTCAT-3′及足够数量的设计的分子信标探针5′-CY5-TAGCCCTCCGCTCCCGCAGGCCACGCTA-BHQ2-3′;
5、取已知基因突变类型的DNA样品830A,并在已知基因突变类型的DNA样品830A中加入了设计的单链DNA5′-ATCGATTAGGGTGTCCAGCGCGCGTGGTGGGCTAGCTCAT-3′及足够数量的设计的分子信标探针5′-CY5-TAGCCCTCCGCTCCCGCAGGCCACGCTA-BHQ2-3′;所述设计的单链DNA 5′-ATCGATTAGGGTGTCCAGCGCGCGTGGTGGGCTAGCTCAT-3′与计的分子信标探针5’-CY5-TAGCCCTCCGCTCCCGCAGGCCACGCTA-BHQ2-3′之间有7个基因突变位点。
6、取待测样品830B,并在待测样品830B中加入了设计的单链DNA5′-ATCGATTAGGGTGTCCAGCGCGCGCGGTGGGCTAGCTCAT-3′及足够数量的设计的分子信标探针5′-CY5-TAGCCCTCCGCTCCCGCAGGCCACGCTA-BHQ2-3′。
7、准备可对加热温度曲线进行控制的加温设备。
8、准备荧光亮度检测设备。
实验并记录:
分别对上述样品810A、810B、820A、820B、830A、830B、840进行加温,加温方式均采用图12所述的加温曲线1200(当然可以采用其他加温曲线,只要在对比测试中待测样品与基因突变类型的DNA样品保持加温曲线一致即可),并使用荧光亮度检测设备分别对样品810A、810B、820A、820B、830A、830B、840对应的荧光亮度实时记录。得到如图9所示的时间-荧光亮度曲线,其中,样品810A对应的解链时间-荧光亮度曲线为910A,样品810B对应的解 链时间-荧光亮度曲线为910B,样品820A对应的解链时间-荧光亮度曲线为920A,样品820B对应的解链时间-荧光亮度曲线为920B,样品830A对应的解链时间-荧光亮度曲线为930A,样品830B对应的解链时间-荧光亮度曲线为930B。
结论
将已知基因突变类型的DNA样品的解链时间-荧光亮度曲线910A、920A、920A与待检测样品DNA的解链时间-荧光亮度曲线910B、920B、930B进行比较,对应曲线高度重合,同时将对应曲线的数值放入皮尔逊相关系数公式可得对应曲线的相关性为0.999。可以得到:
解链时间-荧光亮度曲线910B对应检测样品(编号810B)中的目标DNA有5个基因突变位点;
解链时间-荧光亮度曲线920B对应检测样品(编号820B)中的目标DNA有6个基因突变位点;
解链时间-荧光亮度曲线930B对应检测样品(编号830B)中的目标DNA有7个基因突变位点。
实施例五
一种检测和分析DNA基因突变的位点数量和变异碱基位点的碱基类型的方法,实验方法原理如图10所示,即分别对待测样品(确定已发生基因突变)、已知基因突变类型的DNA样品进行加温。
实验准备:
1、取已知基因突变类型的DNA样品1010A,并在已知基因突变类型的DNA样品1010A)中加入了设计的单链DNA5′-GTAGTTGGAGCTGATGGCGTAGGCAAGAGT-3′及足够数量的设计的分子信标探针5′-CY3-TCTACGCCACCAGCTCA-BHQ2-3′;所述设计的单链DNA
与计的分子信标探针5′-CY3-TCTACGCCACCAGCTCA-BHQ2-3′之间有1个基因突变位点,变异碱基由原来G变为A(序列中被用正方形框出)。
2、取待测样品1010B,并在待测样品1010B中加入了设计的单链DNA5′-GTAGTTGGAGCTGATGGCGTAGGCAAGAGT-3′及足够数量的设计的分子信标探针5′-CY3-TCTACGCCACCAGCTCA-BHQ2-3′;
3、取已知基因突变类型的DNA样品1020A,并在已知基因突变类型的DNA样品1020A中加入了设计的单链DNA5′-GTAGTTGGAGCTGTTGGCGTAGGCAAGAGT-3′及足够数量的设计的分子信标探针5′-CY3-TCTACGCCACCAGCTCA-BHQ2-3′;所述设计的单链DNA
与计的分子信标探针5′-CY3-TCTACGCCACCAGCTCA-BHQ2-3′之间有1个基因突变位点,变异碱基由原来G变为T(序列中被用正方形框出)。
4、取待测样品1020B,并在待测样品1020B中加入了设计的单链DNA5′-GTAGTTGGAGCTGTTGGCGTAGGCAAGAGT-3′及足够数量的设计的分子信标探针5′-CY3-TCTACGCCACCAGCTCA-BHQ2-3′;
5、取已知基因突变类型的DNA样品1030A,并在已知基因突变类型的DNA样品1030A中加入了设计的单链DNA5′-GTAGTTGGAGCTGCTGGCGTAGGCAAGAGT-3′及足够数量的设计的分子信标探针5′-CY3-TCTACGCCACCAGCTCA-BHQ2-3′;所述设计的单链DNA
与计的分子信标探针5′-CY3-TCTACGCCACCAGCTCA-BHQ2-3′之间有1个基因突变位点,变异碱基由原来G变为C(序列中被用正方形框出)。
6、取待测样品1030B,并在待测样品1030B中加入了设计的单链DNA5′-GTAGTTGGAGCTGCTGGCGTAGGCAAGAGT-3′及足够数量的设计的分子信标探针5′-CY3-TCTACGCCACCAGCTCA-BHQ2-3′。
7、准备可对加热温度曲线进行控制的加温设备。
8、准备荧光亮度检测设备。
实验并记录:
分别对上述样品1010A、1010B、1020A、1020B、1030A、1030B进行加温,加温方式均采用图12所述的加温曲线1200(当然可以采用其他加温曲线, 只要在对比测试中待测样品与基因突变类型的DNA样品保持加温曲线一致即可),并使用荧光亮度检测设备分别对样品1010A、1010B、1020A、1020B、1030A、1030B对应的荧光亮度实时记录。得到如图11所示的时间-荧光亮度曲线,其中,样品1010A对应的解链时间-荧光亮度曲线为1110A,样品1010B对应的解链时间-荧光亮度曲线为1110B,样品1020A对应的解链时间-荧光亮度曲线为1120A,样品1020B对应的解链时间-荧光亮度曲线为1120B,样品1030A对应的解链时间-荧光亮度曲线为1130A,样品1030B对应的解链时间-荧光亮度曲线为1130B,样品1040对应的解链时间-荧光亮度曲线为1140。
结论
将已知基因突变类型的DNA样品的解链时间-荧光亮度曲线1110A、1120A、1120A与待检测样品DNA的解链时间-荧光亮度曲线1110B、1120B、1130B进行比较,对应曲线高度重合,同时将对应曲线的数值放入皮尔逊相关系数公式可得对应曲线的相关性为0.999。可以得到:
解链时间-荧光亮度曲线1110B对应检测样品1010B中的目标DNA有1个基因突变位点,且变异碱基由原来G变为A;
解链时间-荧光亮度曲线1120B对应检测样品1020B中的目标DNA有1个基因突变位点,且变异碱基由原来G变为T;
解链时间-荧光亮度曲线1130B对应检测样品1030B中的目标DNA有1个基因突变位点,且变异碱基由原来G变为C。
从上可知,该方法可以用于检测DNA突变(mutation)及其数量、变异碱基位点的碱基类型或者单核苷酸多态性基因型分型(SNP,single nucleotide polymorphism genotyping)。
以上所述仅是本发明的优选实施例,本发明的保护范围并不仅局限于上述实施例,凡属于本发明思路下的技术方案均属于本发明的保护范围。应当指出,对于本技术领域的普通技术人员来说,在不脱离本发明原理前提下的若干改进和润饰,如改变分子信标探针为其他能够标识和标记DNA 特异性的物质,将标准DNA、已知基因突变类型的DNA样品及待测样品进行检测比对分析等,这些改进和润饰也应视为本实用新型的保护范围。
Claims (12)
- 一种检测DNA的方法,其特征在于,其包括如下步骤:获取对照组DNA的解链时间-荧光亮度曲线;获取检测样品DNA的解链时间-荧光亮度曲线;将对照组DNA的解链时间-荧光亮度曲线与检测样品DNA的解链时间-荧光亮度曲线进行比较,获得检测结果。
- 根据权利要求1所述的一种检测DNA的方法,其特征在于,所述对照组为空白对照组。
- 根据权利要求1所述的一种检测DNA的方法,其特征在于,所述对照组为标准DNA。
- 根据权利要求1所述的一种检测DNA的方法,其特征在于,所述对照组为已知突变类型的DNA。
- 根据权利要求1-4中任意一个所述的一种检测DNA的方法,其特征在于,在反应溶液中放入分子信标探针和DNA靶,对反应溶液进行加温,同时,对其荧光信号进行记录,获取DNA的解链时间-荧光亮度曲线。
- 根据权利要求5所述的一种检测DNA的方法,其特征在于,在获取对照组DNA和获取检测样品DNA的解链时间-荧光亮度曲线过程中,两者加温过程的加温曲线保持一致。
- 根据权利要求5所述的一种检测DNA的方法,其特征在于,对其荧光信号进行实时记录。
- 根据权利要求1所述的一种检测DNA的方法,其特征在于,该方法用于DNA突变检测或DNA同源检测或目标DNA有无检测。
- 一种检测DNA的方法,其特征在于,通过获取检测样品DNA的解链时间-荧光亮度曲线获得有或无目标DNA的检测结果。
- 一种通过获取DNA的解链时间-荧光亮度曲线分析DNA的方法。
- 根据权利要求10所述的一种分析DNA的方法,其特征在于,在反应溶 液中放入分子信标探针和DNA靶,对反应溶液进行加温,同时,对其荧光信号进行记录,获取DNA的解链时间-荧光亮度曲线。
- 根据权利要求10所述的一种分析DNA的方法,其特征在于,该方法用于DNA突变分析或DNA同源分析或目标DNA有无分析。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711499798.9A CN107937485A (zh) | 2017-12-29 | 2017-12-29 | 一种检测和分析dna的方法 |
CN201711499798.9 | 2017-12-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2019128081A1 true WO2019128081A1 (zh) | 2019-07-04 |
Family
ID=61937254
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2018/088762 WO2019128081A1 (zh) | 2017-12-29 | 2018-05-28 | 一种检测和分析dna的方法 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN107937485A (zh) |
WO (1) | WO2019128081A1 (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107937485A (zh) * | 2017-12-29 | 2018-04-20 | 澳门大学 | 一种检测和分析dna的方法 |
CN110585754B (zh) * | 2019-09-03 | 2020-12-08 | 珠海市迪奇孚瑞生物科技有限公司 | 用于干燥的试剂混合物、试剂混合物的制备以及干燥方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006020775A2 (en) * | 2004-08-13 | 2006-02-23 | Harvard University | An ultra high-throughput opti-nanopore dna readout platform |
CN104651529A (zh) * | 2015-03-24 | 2015-05-27 | 厦门大学 | 一种检测核酸分子缺失突变的方法 |
CN104962653A (zh) * | 2015-07-28 | 2015-10-07 | 上海睿玻生物科技有限公司 | 亚甲基四氢叶酸还原酶基因多态性检测的试剂盒及检测方法 |
CN107937485A (zh) * | 2017-12-29 | 2018-04-20 | 澳门大学 | 一种检测和分析dna的方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7387887B2 (en) * | 2004-04-20 | 2008-06-17 | University Of Utah Research Foundation | Nucleic acid melting analysis with saturation dyes |
EP2336358A1 (en) * | 2008-05-06 | 2011-06-22 | QIAGEN GmbH | Simultaneous detection of multiple nucleic acid sequences in a reaction |
CN103088137B (zh) * | 2013-01-18 | 2014-11-05 | 陕西北美基因股份有限公司 | 一种利用探针熔解技术准确检测kras基因突变的方法 |
US9751083B2 (en) * | 2015-04-07 | 2017-09-05 | University Of Macau | Electronic module for real-time droplet-position sensing and driving in digital microfluidic system |
-
2017
- 2017-12-29 CN CN201711499798.9A patent/CN107937485A/zh active Pending
-
2018
- 2018-05-28 WO PCT/CN2018/088762 patent/WO2019128081A1/zh active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006020775A2 (en) * | 2004-08-13 | 2006-02-23 | Harvard University | An ultra high-throughput opti-nanopore dna readout platform |
CN104651529A (zh) * | 2015-03-24 | 2015-05-27 | 厦门大学 | 一种检测核酸分子缺失突变的方法 |
CN104962653A (zh) * | 2015-07-28 | 2015-10-07 | 上海睿玻生物科技有限公司 | 亚甲基四氢叶酸还原酶基因多态性检测的试剂盒及检测方法 |
CN107937485A (zh) * | 2017-12-29 | 2018-04-20 | 澳门大学 | 一种检测和分析dna的方法 |
Also Published As
Publication number | Publication date |
---|---|
CN107937485A (zh) | 2018-04-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7067896B2 (ja) | 品質評価方法、品質評価装置、プログラム、および記録媒体 | |
JP7545511B2 (ja) | デジタルpcrの測定方法および測定装置 | |
Nakagawa et al. | 10-Plex digital polymerase chain reaction with four-color melting curve analysis for simultaneous KRAS and BRAF genotyping | |
CN105441562A (zh) | Carl基因缺失、插入突变的检测方法及试剂盒 | |
WO2019128081A1 (zh) | 一种检测和分析dna的方法 | |
JP5590781B2 (ja) | 標的核酸比率推定方法 | |
CN110863053A (zh) | 一种检测EGFR vIII突变体的引物、探针及方法 | |
JPWO2019045016A1 (ja) | 高感度かつ定量的な遺伝子検査方法、プライマーセット、及び検査キット | |
US20220372577A1 (en) | Analyte detection method | |
CN104087672A (zh) | 一种多重实时荧光定量pcr技术快速检测人21号染色体数目的试剂盒 | |
Ma et al. | Ultrafast and Highly Specific Detection of One-Base Mutated Cell-Free DNA at a Very Low Abundance | |
CN104988239A (zh) | 一种快速分析单细胞性染色体倍性的方法和试剂盒 | |
CN104087671A (zh) | 一种用于检测人21号染色体数目的试剂盒 | |
CN104073548A (zh) | 基于溶解曲线的单核苷酸多态性检测方法及其试剂盒 | |
CN106811537A (zh) | 一种检测表皮生长因子受体基因t790m低频突变引物及其应用 | |
Barbosa et al. | Y Chromosome sequences in Turner syndrome: multiplex PCR, a new method for diagnosis | |
JP2022517008A (ja) | 脊髄性筋萎縮症の識別のための方法およびシステム | |
EP4092134A1 (en) | Method and system for dna detection | |
Chi et al. | Colorimetric detection of African swine fever (ASF)-associated microRNA based on rolling circle amplification and salt-induced gold nanoparticle aggregation | |
WO2022259334A1 (ja) | Dna検出方法およびdna検出システム | |
JP2011244815A (ja) | JAK2遺伝子のexon12における変異の検出法、ならびにそのための核酸プローブおよびキット | |
RU2688189C1 (ru) | Панель последовательностей олигонуклеотидов для определения мутации Q61R гена NRAS в опухолевых образованиях щитовидной железы | |
Jyothy et al. | REAL-TIME PCR OR QUANTITATIVE PCR (QPCR)–A REVOLUTION IN MODERN SCIENCE | |
CN117904264A (zh) | Dna重测序结果差异化检测比对方法 | |
RU2499994C1 (ru) | Способ определения чувствительности опухоли легкого к терапии ингибиторами тирозинкиназ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 18893552 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 18893552 Country of ref document: EP Kind code of ref document: A1 |